Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 39,700Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 5Seretide/Advair

PharmaCompass

01

Brand Name : Seretide/Advair

Salmeterol

arrow
PackExpo
Not Confirmed

Brand Name : Seretide/Advair

arrow
PackExpo
Not Confirmed

Salmeterol

Main Therapeutic Indication : Respiratory Disorders

Currency : USD

2020 Revenue in Millions : 2,128

2019 Revenue in Millions : 2,398

Growth (%) : -11

blank

02

Brand Name : Seretide/Advair

Salmeterol

arrow
PackExpo
Not Confirmed

Brand Name : Seretide/Advair

arrow
PackExpo
Not Confirmed

Salmeterol

Main Therapeutic Indication : Respiratory Disorders

Currency : USD

2021 Revenue in Millions : 1,836

2020 Revenue in Millions : 2,103

Growth (%) : -12

blank

03

Brand Name : Seretide/Advair

Salmeterol

arrow
PackExpo
Not Confirmed

Brand Name : Seretide/Advair

arrow
PackExpo
Not Confirmed

Salmeterol

Main Therapeutic Indication : Respiratory Diseases

Currency : USD

2022 Revenue in Millions : 1,429

2021 Revenue in Millions : 1,836

Growth (%) : -22

blank

04

Brand Name : Seretide/Advair

Salmeterol

arrow
PackExpo
Not Confirmed

Brand Name : Seretide/Advair

arrow
PackExpo
Not Confirmed

Salmeterol

Main Therapeutic Indication : Respiratory Diseases

Currency : USD

2023 Revenue in Millions : 1,229

2022 Revenue in Millions : 1,429

Growth (%) : -2

blank

05

Brand Name : Seretide/Advair

Salmeterol

arrow
PackExpo
Not Confirmed

Brand Name : Seretide/Advair

arrow
PackExpo
Not Confirmed

Salmeterol

Main Therapeutic Indication : Respiratory Disorders

Currency : USD

2019 Revenue in Millions : 2,145

2018 Revenue in Millions : 3,003

Growth (%) : -29

blank